Expression of Embryonic Fibronectin Isoform EIIIA Parallels α-Smooth Muscle Actin in Maturing and Diseased Kidney

Abstract

In this study we examined if an association exists between expression of an alternatively spliced “embryonic” fibronectin isoform EIIIA (Fn-EIIIA) and α-smooth muscle actin (α-SMA) in the maturing and adult rat kidney and in two unrelated models of glomerular disease, passive accelerated anti-glomerular basement membrane (GBM) nephritis and Habu venom (HV)-induced proliferative glomerulonephritis, using immunohistochemistry and in situ hybridization. Fn-EIIIA and α-SMA proteins were abundantly expressed in mesangium and in periglomerular and peritubular interstitium of 20-day embryonic and 7-day (D-7) postnatal kidneys in regions of tubule and glomerular development. Staining was markedly reduced in these structures in maturing juvenile (D-14) kidney and was largely lost in adult kidney. Expression of Fn-EIIIA and α-SMA was reinitiated in the mesangium and the periglomerular and peritubular interstitium in both models and was also observed in glomerular crescents in anti-GBM nephritis. Increased expression of Fn-EIIIA mRNA by in situ hybridization corresponded to the localization of protein staining. Dual labeling experiments verified co-localization of Fn-EIIIA and α-SMA, showing a strong correlation of staining between location and staining intensity during kidney development, maturation, and disease. Expression of EIIIA mRNA corresponded to protein expression in developing and diseased kidneys and was lost in adult kidney. These studies show a recapitulation of the co-expression of Fn-EIIIA and α-SMA in anti-GBM disease and suggest a functional link for these two proteins.

Keywords

fibronectin alternative splicing smooth muscle actin mesangium glomerulonephritis interstitial nephritis fibrosis

Activation of mesenchymal cells has been associated with a switch to an α-smooth muscle actin (α-SMA) phenotype during proliferation and fibrosis in a variety of disease settings (Sappino et al. 1990; Johnson et al. 1991,1992; Kuhn and McDonald 1991; Alpers et al. 1992,1996; Jarnagin et al. 1994; Schmitt-Graff et al. 1994; Berndt et al. 1995; Boukhalfa et al. 1996; Tuchweber et al. 1996; Serini et al. 1998). In the kidney, it is well established that mesangial cells during glomerulonephritis and fibroblasts in interstitial nephritis are converted from a resting cell phenotype to a myofibroblast-like cell during injury, acquiring the expression of α-SMA (Johnson et al. 1991; Alpers et al. 1992,1996; Johnson et al. 1992; Barnes et al. 1994a,1995b; Boukhalfa et al. 1996; El Nahas et al. 1996; Kliem et al. 1996; Tang et al. 1997). Factors involved in the phenotypic changes in mesenchymal cells remain unknown. However, prolonged culture and exposure to growth factors and extracellular matrix proteins activate the cells and elicit the expression of this cytoskeletal protein in several cell types such as liver fat-storing cells (Ito cells), breast stromal cells, fibroblasts, brain pericytes, and glomerular mesangial cells (Sappino et al. 1990; Elger et al. 1993; Jarnagin et al. 1994; Schmitt-Graff et al. 1994; Serini et al. 1998).

Recent interest has centered on a role for fibronectin (Fn), particularly an isoform containing an extra domain EIIIA (Fn-EIIIA), as a mediator of mesenchymal cell activation. The functions of the EIIIA domain are not known. However, its close proximity to the RGDS cell binding domain suggests that this isoform has specific functional roles (Schwarzbauer et al. 1985; Paul et al. 1986; Hynes 1990; Schwarzbauer 1991; ffrench-Constant 1995). The Fn-EIIIA variant is abundantly expressed during embryogenesis (ffrench-Constant and Hynes 1988,1989; Peters and Hynes 1996) and at the margins of healing wounds (ffrench-Constant et al. 1989; Brown et al. 1993), whereas this domain is spliced out of plasma Fn (derived from hepatocytes) and many tissue-specific cells in adult tissues (Peters et al. 1996), suggesting that it has important functions in remodeling (Paul et al. 1986; Schwarzbauer 1991; ffrench-Constant 1995). Functions for Fn-EIIIA have not been determined, but a close association with cells undergoing high rates of migration, proliferation, and differentiation suggests a role in cell activation (Schwarzbauer et al. 1985; ffrench-Constant and Hynes 1988,1989; ffrench-Constant et al. 1989; Hynes 1990; Schwarzbauer 1991; Brown et al. 1993; Barnes et al. 1994a,1995b; ffrench-Constant 1995; Peters and Hynes 1996).

Fn protein has been detected in glomeruli and the interstitium in developing kidney decreasing in intensity during maturation (Mounier et al. 1986; Peters and Hynes 1996; Peters et al. 1996). Similarly, α-SMA localizes in mesangial and peritubular structures during kidney development but is lost in adult kidney (Carey et al. 1992). Fn localizes in glomeruli and the peritubular interstitium in renal disease (Barnes et al. 1994a, 1995b; Yamamoto et al. 1994; Nickeleit et al. 1995; Alpers et al. 1996; El Nahas et al. 1996; Kliem et al. 1996), similar to areas of increased α-SMA expression during fibrosis, suggesting that these two proteins may be associated in tissues undergoing high rates of remodeling. However, the studies listed above examined localization of either Fn or α-SMA alone and did not examine if these two proteins co-localize or follow the same course of expression. Moreover, expression of Fn-EIIIA isoform in renal disease has been examined (Barnes et al. 1994a, b; Yamamoto et al. 1994; Nickeleit et al. 1995; Alonso et al. 1996), but correlations between this isoform and α-SMA expression have not been determined. Similarly, it is not known if the Fn-EIIIA isoform and α-SMA co-localize and follow the same course of expression during renal maturation. Because the Fn-EIIIA isoform may have an important role in cell activation in the kidney during nephrogenesis and remodeling, we examined the course of expression of Fn-EIIIA mRNA and the co-localization of these two proteins in embryonic, maturing, and adult kidney and in two unrelated models of renal disease characterized by mesangial cell proliferation, interstitial nephritis, and/or glomerular crescents. The results showed that Fn-EIIIA and α-SMA co-localize and follow the same course of expression during kidney development and maturation and that a recapitulation of co-expression occurs in the mesangium and interstitium during renal disease.

Materials and Methods

Embryonic, Juvenile, and Adult Kidney

To examine the course of expression of Fn-EIIIA and α-SMA during kidney maturation, kidneys were obtained from 20-day embryos just before birth (rat gestation is 22 days), 7- (D-7) and 14-day (D-14) postnatal juveniles, and 6-8-week adult Sprague-Dawley rats (Charles River; Raleigh, NC). Kidney tissue was sliced and immediately frozen in liquid nitrogen, and stored in cryogenic tubes at −70C for subsequent immunohistochemistry and in situ hybridization.

Induction of Anti-glomerular Basement Membrane (GBM) Nephritis

Anti-GBM Antibody. Glomeruli were isolated from Sprague-Dawley rat kidneys by differential sieving and GBM was purified according to the methods of Meezan et al. (1975). Rabbits were immunized with 100 μg GBM in complete Freund's adjuvant, followed 10 days later with an equal amount of antigen in Freund's incomplete adjuvant. The rabbits received periodic booster injections of 50-100 μ g GBM in saline IV and were bled 10 days after each boost. All sera were pooled and an immunoglobulin fraction was obtained by 50% ammonium sulfate precipitation. The antibody was dialyzed against 0.02 M PBS pH 7.4, protein concentration quantified, sterile-filtered, and stored at — 70C until needed.

Protocol

An accelerated nephrotoxic nephritis was induced according to the methods of Lan et al. (1991). Nine rats were immunized with 5 mg rabbit IgG in Freund's complete adjuvant. Five days later the rats were divided into two groups, one challenged with 15 mg rabbit anti-GBM IgG in PBS (n = 5) IV and the other an untreated control group (n = 4). The rats were sacrificed at 3 weeks after the initial anti-GBM injection. At sacrifice, renal cortex was excised and frozen or fixed in 10% neutral buffered formalin for subsequent immunohistochemistry, in situ hybridization, and histological evaluation.

Proliferative Glomerulonephritis Induced by Habu Venom (HV)

To examine an association between Fn-EIIIA and α-SMA in lesions in a model of nonimmune glomerular disease, five rats were injected with HV as previously reported (Barnes 1989; Barnes and Abboud 1993; Barnes et al. 1994a, b, 1995b). Briefly, the rats were unilaterally nephrectomized to increase the incidence of subsequent glomerular lesions and 24 hr later they were injected with HV (Trimeresurus flavoviridis; Sigma Chemical, St Louis, MO) at a dose of 3.5 mg/kg IV. Seventy-two hr after injection of HV, the rats were sacrificed and tissue was taken for subsequent morphological analysis, immunohistochemistry, and in situ hybridization. Lesions at 72 hr after HV are characterized by focal and segmental proliferative micronodules composed almost exclusively of mesangial cells (Barnes 1989; Barnes and Abboud 1993; Barnes et al. 1994b).

Immunohistochemical Localization of Fn-EIIIA and α-SMA Proteins

Localization of Fn-EIIIA and α-SMA was assessed by immunofluorescence and immunoperoxidase histochemistry using mouse monoclonal antibodies (MAbs) specific for the alternatively spliced extra domain (EIIIA) of cellular Fn (clones 3E2, Sigma and IST-9, Serotec; Harlan Bioproducts for Science, Indianapolis, IN). Mouse anti-human α-SMA MAb clone 1A4 was obtained from Sigma. Acetone-fixed frozen sections (6 μ m) were treated as previously described (Barnes 1989; Barnes and Abboud 1993; Barnes et al. 1994b). Sections were incubated with nonimmune IgG of the same species as the second antibody to block nonspecific binding, then with primary antibody followed by FITC- or biotinlabeled second antibodies [rat anti-mouse IgM MAb (Sigma) or donkey anti-mouse IgG MAb (Chemicon International; Temecula, CA)]. Second antibodies were adsorbed with IgGs of a variety of species (other than the primary) to avoid crossreactivity with endogenous rat IgG or to exogenous rabbit IgG administered to elicit anti-GBM nephritis. Sections employing the avidin-biotin complex (ABC; Vector Laboratories, Burlingame, CA) technique for immunoperoxidase were incubated with 0.6% hydrogen peroxide in methanol to block nonspecific peroxidase activity and 0.01% avidin, 0.001% biotin to block endogenous biotin activity. All incubations of primary and second antibody were for 30 min with three washes with PBS containing 0.1% bovine serum albumin (BSA), 5 min each between steps. Controls consisted of nonimmune mouse IgM, IgG, or PBS-BSA in place of primary antibody, followed by detection procedures as outlined above.

Dual Label Immunohistochemistry

To verify co-localization of EIIIA and α-SMA, dual label immunohistochemistry was employed utilizing two separate fluorescence tags. Tissue sections of representative kidneys of D-7 juveniles, anti-GBM, and 72-hr HV experiments were incubated with anti-Fn-EIIIA antibody followed by an affinity-purified FITC-labeled donkey anti-mouse IgG adsorbed with IgG derived from multiple species for dual labeling (Chemicon International). α-SMA was detected by direct immunostaining utilizing a Cy3-labeled mouse MAb (Sigma). Sections were washed with PBS-BSA between all antibody incubations. In addition, sections were incubated with normal nonimmune mouse IgG immediately before Cy3-anti-α-SMA to prevent potential binding of this labeled primary to the localized FITC-labeled second anti-mouse IgG antibody. Sections were viewed and photographed using an Olympus Research microscope equipped for epifluorescence using excitation and bandpass filters optimal for either FITC or Cy3. Sections incubated with anti Fn-EIIIA and FITC-second antibody viewed with the Cy3 filter set and Cy3-anti-α-SMA viewed with the FITC filter set were negative, indicating efficient barrier filtration of cross-illumination from the opposing fluorochromes.

In Situ Hybridization

Synthesis of riboprobe, tissue preparation, in situ hybridization and autoradiography were identical to methods used previously (Barnes et al. 1994a,1995a, b). Briefly, cDNA probes containing a 160-BP alternatively spliced region EIIIA [generously provided by Dr. Richard O. Hynes, Massachusetts Institute of Technology (Paul et al. 1986)] and a 130-BP fragment derived from the 3'-untranslated rat α-SMA mRNA that is specific for α-SMA transcript (Kocher and Gabbiani 1987) (generously provided by Dr. Gabriel Gabbiani, University of Geneva) were used for generation of ³⁵ S-labeled riboprobes to detect cellular localization of mRNA in sections of renal tissue. All experiments were performed simultaneously with the sense riboprobe as a negative control.

Preparation of Riboprobes

Linearized cDNA was transcribed in vitro using a Riboprobe system II kit (Promega; Madison, WI) according to the manufacturer's instructions. Either SP6 or T7 RNA polymerase and [³⁵ S]-uridine-5'-(a-thio)-triphosphate (1300 Ci/mMol; New England Nuclear, Boston, MA) were included in the reaction mixture to generate [³⁵ S]-labeled antisense and sense riboprobes. The reaction mixture was incubated for 60 min at 40C, and then the DNA template was removed by digestion with 0.5 U RNase-free DNase, followed by removal of unincorporated nucleotides by phenol-chloroform extraction and ethanol precipitation. RNA probes (activity approximately 4 × 10⁶ CPM/μl) were stored at — 70C and used within 3 days.

Tissue Preparation

Frozen sections (6 μm) were cut and collected on aminosilane-glutaraldehyde-treated slides, then fixed for 20 min in 4% paraformaldehyde in 0.01 M PBS, pH 7.4. The sections were washed twice in PBS, dehydrated through a graded series of ethanols, air-dried, and used immediately for in situ hybridization.

Tissue Hybridization

In situ hybridization procedures were performed as previously described, involving prehybridization, hybridization, and removal of nonspecifically bound probe. Prehybridization steps included treatment with 0.2 N HCl, proteinase K (1 μ g/ml), and acetic anhydride to block background and enhance probe penetration. Twenty-five μ l of hybridization mixture containing 50% formamide, 10% dextran sulfate, 10 mM dithiothreitol, 0.1 M Tris-HCl, pH 7.5, 0.1 M NaPO₄, 0.3 M NaCl, 50 mM EDTA, 1 × Denhardt's solution, 0.2 mg/ml yeast tRNA, and 2 × 10⁵ cpm of ³⁵ S-labeled riboprobe was applied to each section and covered with a siliconized coverslip. Hybridizations with EIIIA probes were performed in a sealed humid chamber for 18 hr at 50C. α-SMA probes were very sticky, possibly due to a high content of G-C (75%) in the first half of the strand, and were hybridized at 58C. Excess probe was removed by washing slides in TE buffer, treatment with RNase A to decrease nonspecific background activity, and rinsing in 2 × SSC. Sections were dehydrated in graded ethanols, air-dried, and immersed in the dark in Kodak NTB-2 photographic emulsion (Eastman-Kodak; Rochester, NY). After air-drying the sections were exposed for 2-3 weeks at 4C. The emulsion was developed and sections were stained with hematoxylin and eosin for subsequent bright- and darkfield microscopic analysis.

Results

Embryonic, Juvenile, and Adult Kidney

Expression of Fn-EIIIA and α-SMA is very similar in the renal parenchyma in the late embryo and early developing kidney, showing a nearly parallel localization of these two proteins in the glomerular mesangium and peritubular interstitium. Interstitial expression of both proteins also showed a parallel reduction of expression in the maturing and adult kidney, but glo-merular α-SMA expression appeared to be preferentially reduced relative to Fn-EIIIA at the D-14 timepoint and beyond. Maturation of the metanephric parenchyma occurs in an outward direction from the interior towards the outer aspect of the cortex, with newly developing structures in the most peripheral aspect of the kidney and more mature structures deeper within the cortex. The pattern of expression of Fn-EIIIA and α-SMA protein followed this course, showing strongest intensity of staining in the peritubular and periglomerular interstitial mesenchymal cells and in the glomerular mesangium (Figures 1A and 1B) in developing cortex in 20-day embryos and in the outermost aspects of the cortex in D-7 kidneys (Figures 1C and 1D). Staining of Fn-EIIIA and α-SMA in more mature structures in the inner aspects of the cortex in D-7 kidneys showed less intensity of staining (Figures 1C, 1D, 2A, and 2B). Staining for both Fn-EIIIA and α-SMA in D-14 kidneys was substantially reduced and showed weak but evenly distributed staining of peritubular and periglomerular structures throughout the cortex (Figures 1E and 1F). Glomeruli expressed Fn-EIIIA and α-SMA in D-14 kidneys. However, staining intensity of α-SMA diminished, particularly in more mature glomeruli, towards the inner cortex. In adult kidneys, staining for Fn-EIIIA (Figure 1G) was lost in the peritubular and periglomerular interstitium, but the glomerular mesangium retained weak staining. Expression of α-SMA (Figure 1H) was entirely lost in the peritubular interstitium and glomerular mesangium throughout the kidney cortex in adult cortex. Dual labeling experiments verified a close correlation of Fn-EIIIA and α-SMA staining in peritubular and glomerular structures in maturing (D-7) kidney (Figures 2A and 2B). However, renal parenchyma destined to become arterial and arteriolar structures in embryonic tissue, as well as arteries and arterioles in maturing and adult kidney, showed a departure from the parallel staining pattern and stained intensely for α-SMA but weakly for Fn-EIIIA (Figures 1C–1H).

Anti-GBM Nephritis

Anti-GBM nephritis was characterized by a mild mesangial proliferative glomerulonephritis, glomerular crescents, and focal areas of interstitial nephritis characterized by tubular atrophy and interstitial expansion. Expression of Fn-EIIIA and α-SMA protein was evident in all areas of disease and showed a distribution similar to that described for developing kidney, with strong staining in the periglomerular and peritubular interstitium and the mesangium (Figures 2C, 2D, and 3A–3D). Glomerular crescents also stained strongly for Fn-EIIIA and α-SMA (Figures 3A and 3B). Co-localization of Fn-EIIIA and α-SMA staining was verified by dual label immunofluorescence microscopy, showing a correlation between location, staining intensity, and severity of lesions in peritubular interstitium (Figures 2C and 2D) and glomeruli.

HV-induced Glomerulonephritis

Administration of HV results in an accelerated proliferative glomerulonephritis characterized by mesangiolysis, development of microaneurysms, and resulting in mesangial proliferative lesions by 72 hr after injection (Barnes 1989; Barnes and Abboud 1993; Barnes et al. 1994b,1995a). In all kidneys studied, micronodules stained intensely for Fn-EIIIA and α-SMA (Figures 2E, 2F, 3E, and 3F). Periglomerular and peritubular structures stained weakly for Fn-EIIIA and α-SMA (Figures 2E, 2F, 3E, and 3F). Dual label immunofluorescence verified a co-localization of both proteins in all lesions examined (Figures 2E and 2F).

In Situ Hybridization

Expression of Fn-EIIIA and α-SMA mRNA corresponded to the localization of their respective proteins in embryonic, maturing, adult, and diseased kidneys (Figure 4). Message for Fn-EIIIA was observed in the interstitial mesenchyme and glomeruli, primarily in the deep cortex of 20-day embryos (Figure 4A). It became most concentrated in these same structures in the outer developing cortex of D-7 kidneys (Figure 4B) and was virtually lost in 2-week (Figure 4C) and adult rats. Similarly, Fn-EIIIA mRNA was detected in glomerular crescents and mesangium (Figure 4D) and in periglomerular and peritubular interstitium in areas of interstitial nephritis in anti-GBM rats (Figure 4E). Glomerular micronodules in kidneys from rats with HV-induced nephritis (Figure 4F) and, to a lesser extent, periglomerular and peritubular structures also showed enhanced expression of Fn-EIIIA mRNA. Sense controls showed negligible background staining.

Probes used for the detection of α-SMA mRNA were sticky (see Materials and Methods) and had a high degree of background staining, overshadowing the detail of peritubular expression of α-SMA message. However, specific message was detected above background in areas of high cellular activity, such as the outer aspect of the kidney cortex in D-7 postnatal kidney (Figure 4G), glomerular crescents (Figure 4H), and in HV-induced glomerular micronodules (Figure 4I), identical to areas of abundant expression of Fn-EIIIA mRNA and their respective proteins, as described above.

Discussion

These studies largely show a co-expression of Fn-EIIIA and α-SMA in embryonic and maturing rat kidneys and a recapitulation of expression in two unrelated models of renal disease. Expression of Fn-EIIIA and α-SMA was negligible or absent in adult renal parenchyma. However, a spatial and temporal association between these proteins was evident at sites of high cellular activity and activation during kidney development. Both proteins were expressed in the peritubular interstitium and glomerular mesangium, with staining intensity following the course of cortical development and a parallel reduction in expression during maturation. Fn-EIIIA mRNA was confined to the interstitium, in contrast to developing and maturing tubules, indicating that this Fn isoform is not synthesized by the tubular epithelium and is not a component of mature tubular basement membrane. Instead, Fn-EIIIA may be expressed by mesangial cells and myofibroblasts or their precursors and as a provisional matrix for developing mesenchymal structures, and may be required for capillary growth and glomerulogenesis.

A recapitulation of Fn-EIIIA and α-SMA expression was observed during renal disease, with a coexpression of these proteins in the periglomerular and peritubular interstitium (by myofibroblasts) and in glomerular mesangium, similar to the areas of expression described during kidney development and maturation. A co-localization of Fn-EIIIA and α-SMA was also observed in glomerular crescents in anti-GBM nephritis. The cell types in crescents that may express α-SMA have not been identified but are believed to be myofibroblasts (Atkins et al. 1996) or transdifferentiated epithelial cells (Ng et al. 1998). The close association and course of dual expression of Fn-EIIIA and α-SMA in discrete tissue structures in three different conditions of cellular remodeling (nephrogenesis, proliferative glomerulonephritis, and interstitial disease) suggest that these two proteins are tightly linked and share common functional roles required for remodeling.

Activation of various mesenchymal cells is associated with a switch to an α-SMA-positive phenotype. Recent findings indicate that several cell types, such as liver fat-storing cells (Ito cells), breast stromal cells, fibroblasts, brain pericytes, and glomerular mesangial cells, do not express α-SMA in normal adult tissue or in primary culture. However, prolonged culture or exposure to growth factors activates these cells and elicits the expression of this cytoskeletal protein (Sappino et al. 1990; Johnson et al. 1991,1992; Elger et al. 1993; Schmitt-Graff et al. 1994; Serini et al. 1998). In addition, maintenance of Ito or mesangial cells on a surface that mimics normal basement membrane (i.e., Matrigel, an extract of Englebroth-Holm-Swarm tumor) maintains cellular quiescence and downregulation of α-SMA expression, suggesting that extracellular matrix interactions are important in cell activation (Rockey et al. 1992; DeLuca et al. 1993). Such cellmatrix interactions are supported by the observations that an Fn-EIIIA-enriched substratum induces fibroblast stress fiber formation and activation of a focal adhesion kinase (p125FAK), an important transmembrane signal transduction protein believed to be involved in cell activation (Xia and Culp 1995; Schlaepfer and Hunter 1996). Moreover, a role for Fn-EIIIA in cell activation has been reported in which Ito cells in normal liver and primary culture are α-SMA-negative but can be stimulated to express α-SMA when plated on Fn-EIIIA-fusion protein or endothelial cell-derived Fn-EIIIA, an interaction that could be inhibited by blocking with specific antibody to the EIIIA domain (Jarnagin et al. 1994). Interestingly, Ito cells during liver injury, fibroblasts in fibrotic lung disease, palmar fibromatosis, wound healing, interstitial nephritis, and mesangial cells during glomerulonephritis are converted from a resting cell phenotype to a myofibroblast-like cell during injury, and many of these mesenchymal cells are also associated with Fn-EIIIA during disease (Hynes 1990; Sappino et al. 1990; Kuhn and McDonald 1991; Barnes et al. 1994a,1995b; Jarnagin et al. 1994; Schmitt-Graff et al. 1994; Yamamoto et al. 1994,1996; Berndt et al. 1995; Nickeleit et al. 1995; Alpers et al. 1996; Kliem et al. 1996; Tang et al. 1997; Serini et al. 1998). This study shows for the first time that Fn-EIIIA and α-SMA are temporally and spatially associated in kidney maturation and disease.

Other alternatively spliced isoforms, such as EIIIB, may also have functional roles in embryogenesis and disease (Schwarzbauer 1991; Nickeleit et al. 1995; Peters et al. 1996; Peters and Hynes 1996). Expression of Fn-EIIIA and Fn-EIIIB shows widespread co-distribution in embryonic tissues. However, it shows divergent tissue staining patterns in the adult mouse, suggesting variable functions for alternatively spliced Fn isoforms (Peters et al. 1996; Peters and Hynes 1996). Our previous studies showed a preferential enhancement of Fn-EIIIA mRNA and protein compared to Fn-EIIIB in late HV-induced glomerular lesions at a time when α-SMA was abundant (Barnes et al. 1995b), suggesting that a functional link between these two proteins is unique for the alternatively spliced EIIIA domain.

A functional role for Fn-EIIIA in cell activation and a switch to an α-SMA phenotype have not yet been defined. Remodeling during wound repair or after injury involves cellular behaviors including cell migration, proliferation, and synthesis of extracellular matrix, all of which Fn has been shown to influence (Hynes 1990; Schwarzbauer 1991; ffrench-Constant 1995). Clues to the function of Fn-EIIIA in cell activation can be found in the observation that expression of α-SMA has been related to mesangial cell proliferation (Johnson et al. 1991; Elger et al. 1993) and hypertrophy (Glass et al. 1997) in vitro. Indeed, expression of α-SMA parallels mesangial and Ito cell proliferation and fibrogenesis (Johnson et al. 1991; Alpers et al. 1992,1996; Johnson et al. 1992; Barnes et al. 1994a, 1995b; Jarnagin et al. 1994; Boukhalfa et al. 1996; Tuchweber et al. 1996). Mesangial cells in culture also require their own synthesis of Fn during migration and hillock formation (Glass et al. 1996). Mesangial cells in culture synthesize a matrix abundant in Fn-EIIIA (personal observations), unlike normal adult mesangial cells in vivo (Barnes et al. 1994a, 1995b; Peters et al. 1996; and this report). Therefore, Fn-EIIIA may also have some effect on mesangial cell migration.

We have previously characterized a model of proliferative glomerulonephritis, induced by HV, by a distinct temporal course involving mesangial cell migration, proliferation, and extracellular matrix synthesis (Barnes 1989; Barnes and Abboud 1993; Barnes et al. 1994a,1995a, b). Our previous studies suggest that migrating mesangial cells do not require their own synthesis of Fn-EIIIA but may rely on exogenous sources of Fn isoforms derived from platelets and macrophages (Barnes et al. 1994a,1995b), and agree with our in vitro studies (Barnes and Hevey 1991) showing a potent migratory mesangial cell response to platelet Fn, which is abundant in EIIIA (Paul et al. 1986; Peters et al. 1995). A switch to an α-SMA phenotype appeared to be related to mesangial cell synthesis of Fn-EIIIA and coincided with expression of α-SMA, proliferation, and matrix synthesis, suggesting that autocrine synthesis of Fn-EIIIA by mesangial cells has specific functions during the course of glomerular remodeling. Interestingly, Fn-EIIIA was expressed in early HV-induced glomerular lesions before mesangial cell expression of α-SMA (Barnes et al. 1994a); similar to a recent report by Serini et al. (1998) that ED-A (EIIIA) deposition precedes and then parallels α-SMA expression by fibroblasts during granulation tissue evolution in wound healing.

Serini et al. (1998) also showed that a functional ED-A domain is mandatory for α-SMA induction by transforming growth factor-β1 (TGF-β1). TGF-β1 differentially regulates the expression of Fn-EIIIA in fibroblasts (Borsi et al. 1990) and induces expression of α-SMA in a variety of mesenchymal cells in culture (Desmouliere et al. 1993; Serini et al. 1998). Moreover, TGF-β1 is frequently associated with a switch of fibroblast to a myofibroblast phenotype in liver, lung, and kidney disease (Sappino et al. 1990; Milani et al. 1991; Yamamoto et al. 1994; Zhang et al. 1995), and all three proteins frequently co-localize near myofibroblasts in these disease settings. Therefore, regulation of Fn-EIIIA synthesis by TGF-β1 may provide a functional link for cell activation and α-SMA expression.

These studies show that Fn-EIIIA largely follows a parallel co-expression with α-SMA in several settings of remodeling, including embryonic, maturing, and diseased kidney. An exact role for alternatively spliced Fn-EIIIA in glomerular cell activation (expression of α-SMA) and cell function (migration, proliferation, matrix synthesis, and hypertrophy) has not been determined and remains the focus of current research.

Footnotes

Acknowledgments

Supported by NIH grant DK38758 from the National Institutes of Health (NIDDK), by the Office of Research and Development, Medical Research Service, Department of Veterans Affairs, and by the Southern Arizona Foundation.

We thank Dr George Henderson (Department of Medicine, UTHSCSA) for providing embryonic kidneys for this project. We also thank Drs Richard Hynes, and Gabriel Gabbiani for their generous gifts of cDNA probes to detect Fn-EIIIA and α-SMA mRNA, respectively.

References

Alonso

Gomez-Chiarri

Ortiz

Seron

Condom

Lopez-Armada

Largo

Barat

Egido

(1996) Glomerular upregulation of EIIIA and V120 fibronectin isoforms in proliferative immune complex nephritis. Kidney Int 50:908–919

Alpers

Hudkins

Gown

Johnson

(1992) Enhanced expression of “muscle-specific” actin in glomerulonephritis. Kidney Int 41:1134–1142

Alpers

Pichler

Johnson

(1996) Phenotypic features of cortical interstitial cells potentially important in fibrosis. Kidney Int 49:S-28-31

Atkins

Nikolic-Paterson

Song

Lan

(1996) Modulators of crescentic glomerulonephritis. J Am Soc Nephrol 7:2271–2278

Barnes

(1989) Glomerular localization of platelet secretory proteins in mesangial proliferative lesions induced by Habu snake venom. J Histochem Cytochem 37:1075–1082

Barnes

Abboud

(1993) Temporal expression of autocrine growth factors corresponds to morphological features of mesangial proliferation in Habu snake venom-induced glomerulonephritis. Am J Pathol 143:1366–1376

Barnes

Hastings

De La Garza

(1994a) Sequential expression of cellular fibronectin by platelets, macrophages, and mesangial cells in proliferative glomerulonephritis. Am J Pathol 145:585–597

Barnes

Hevey

(1991) Glomerular mesangial cell migration: response to platelet secretory products. Am J Pathol 138:859–866

Barnes

Hevey

Hastings

Bocanegra

(1994b) Mesangial cell migration precedes proliferation in Habu snake venom-induced glomerular injury. Lab Invest 70:460–467

10.

Barnes

Mitchell

Torres

(1995a) Expression of plasminogen activator-inhibitor-1 (PAI-1) during cellular remodeling in proliferative glomerulonephritis in the rat. J Histochem Cytochem 43:895–905

11.

Barnes

Torres

Mitchell

Peters

(1995b) Expression of alternatively spliced fibronectin variants during remodeling in proliferative glomerulonephritis. Am J Pathol 147:1361–1371

12.

Berndt

Kosmehl

Mandel

Gabler

Luo

Celeda

Zardi

Katenkamp

(1995) TGFβ and bFGF synthesis and localization in Dupuytrens disease (nodular palmar fibromatosis) relative to cellular activity, myofibroblast phenotype and oncofetal variants of fibronectin. Histochem J 27:1014–1020

13.

Borsi

Castellani

Risso

Leprini

Zardi

(1990) Transforming growth factor-β regulates the splicing pattern of fibronectin messenger RNA precursor. FEBS Lett 261:175–178

14.

Boukhalfa

Desmouliere

Rondeau

Gabbiani

Sraer

JD.

(1996) Relationship between alpha-smooth muscle expression and fibrotic changes in human kidney. Exp Nephrol 3:241–247

15.

Brown

Dubin

Lavigne

Logan

Dvorak

Van De Water

(1993) Macrophages and fibroblasts express embryonic fibronectins during cutaneous wound healing. Am J Pathol 142:793–801

16.

Carey

Gomez

(1992) Expression of α-smooth muscle actin in the developing kidney vasculature. Hypertension 19:II-168-175

17.

DeLuca

Konieczkowski

Sedor

(1993) α-smooth muscle cell actin and mesangial cell cytodifferentiation: matrix-adherent cells retain in vivo-like gene expression. J Am Soc Nephrol 4:649A

18.

Desmouliere

Geinoz

Gabbiani

(1993) Transforming growth factor-β 1 induces α-smooth muscle cell actin expression in granulation tissue myofibroblasts and in quiescent and growing cultured fibroblasts. J Cell Biol 122:103–111

19.

Elger

Drenckhahn

Nobiling

Mundel

Kriz

(1993) Cultured rat mesangial cells contain smooth muscle alpha-actin not found in vivo. Am J Pathol 142:497–509

20.

El Nahas

Muchaneta-Kubara

Zhang

Adam

Goumenos

(1996) Phenotypic modulation of renal cells during experimental and clinical renal scarring. Kidney Int 49:S-23-27

21.

ffrench-Constant

(1995) Alternative splicing of fibronectin— many different proteins but few different functions. Exp Cell Res 221:261–271

22.

ffrench-Constant

Hynes

(1988) Patterns of fibronectin gene expression and splicing during cell migration in chicken embryos. Development 104:369–382

23.

ffrench-Constant

Hynes

(1989) Alternative splicing of fibronectin is temporally and spatially regulated in the chicken embryo. Development 106:375–388

24.

ffrench-Constant

Van De Water

Dvorak

Hynes

(1989) Reappearance of an embryonic pattern of fibronectin splicing during wound healing in the adult rat. J Cell Biol 109:903–914

25.

Glass

Karns

Haney

(1997) Smooth muscle α-actin expression and hypertrophy in cultured human mesangial cells. J Am Soc Nephrol 8:515A

26.

Glass

Teng

Haney

(1996) Extracellular matrix distribution and hillock formation in human mesangial cells in culture without serum. J Am Soc Nephrol 7:2230–2243

27.

Hynes

(1990) Fibronectins. New York, Springer-Verlag

28.

Jarnagin

Rockey

Koteliansky

Wang

S-S

Bissell

(1994) Expression of variant fibronectins in wound healing: cellular source and biological activity of the EIIIA segment in rat hepatic fibrogenesis. J Cell Biol 127:2037–2048

29.

Johnson

Floege

Yoshimura

Iida

Couser

Alpers

(1992) The activated mesangial cell: a glomerular “myofibroblast”? J Am Soc Nephrol 2:S190–197

30.

Johnson

Iida

Alpers

Majesky

Schwartz

Pritzl

Gordon

Gown

(1991) Expression of smooth muscle cell phenotype by rat mesangial cells in immune complex nephritis. Alpha-smooth muscle actin is a marker of mesangial cell proliferation. J Clin Invest 87:847–858

31.

Kliem

Johnson

Alpers

Yoshimura

Couser

Koch

Floege

(1996) Mechanisms involved in the pathogenesis of tubulointerstitial fibrosis in 5/6-nephrectomized rats. Kidney Int 49:666–678

32.

Kocher

Gabbiani

(1987) Analysis of α-smooth-muscle actin mRNA expression in rat aortic smooth-muscle cells using a specific cDNA probe. Differentiation 34:201–209

33.

Kuhn

McDonald

(1991) The roles of the myofibroblasts in idiopathic pulmonary fibrosis. Ultrastructural and immunohistochemical features of sites of active extracellular matrix synthesis. Am J Pathol 138:1257–1265

34.

Lan

Paterson

Atkins

(1991) Initiation and evolution of interstitial leukocytic infiltration in experimental glomerulonephritis. Kidney Int 40:425–433

35.

Meezan

Hjelle

Brendel

Carlson

(1975) A simple, versatile, nondisruptive method for the isolation of morphologically and chemically pure basement membranes from several tissues. Life Sci 17:1721–1732

36.

Milani

Herbst

Schuppan

Stein

Surrenti

(1991) Transforming growth factors β1 and β2 are differentially expressed in fibrotic liver disease. Am J Pathol 139:1221–1229

37.

Mounier

Foidart

J-M

Gubler

M-C

Beziau

Lacoste

(1986) Distribution of extracellular matrix glycoproteins during normal development of human kidney. An immunohistochemical study. Lab Invest 54:394–401

38.

Y-Y

Fan

J-M

Nikolic-Paterson

Huang

T-P

Chang

W-C

Atkins

Lan

(1998) Involvement of glomerular epithelial-myofibroblast transdifferentiation (GEMT) in the development of glomerular crescents. J Am Soc Nephrol 9:505A

39.

Nickeleit

Zagachin

Nishikawa

Peters

Hynes

Colvin

(1995) Embryonic fibronectin isoforms are synthesized in crescents in experimental autoimmune glomerulonephritis. Am J Pathol 147:965–978

40.

Paul

Schwarzbauer

Tamkun

Hynes

(1986) Cell-type-specific fibronectin subunits generated by alternative splicing. J Biol Chem 261:12258–12265

41.

Peters

Chen

Hynes

(1996) Fibronectin isoform distribution in the mouse. II. Differential distribution of the alternatively spliced EIIIB, EIIIA, and V segments in the adult mouse. Cell Adhesion Commun 4:127–148

42.

Peters

Hynes

(1996) Fibronectin isoform distribution in the mouse. I. The alternatively spliced EIIIB, EIIIA, and V segments show widespread codistribution in developing mouse embryo. Cell Adhesion Commun 4:103–125

43.

Peters

Trevithick

Johnson

Hynes

(1995) Expression of the alternatively spliced EIIIB segment of fibronectin. Cell Adhesion Commun 3:67–89

44.

Rockey

Boyles

Gabbiani

Friedman

(1992) Rat hepatic lipocytes express smooth muscle actin upon activation in vivo and in culture. J Submicrosc Cytol Pathol 24:193–203

45.

Sappino

A-P

Schurch

Gabbiani

(1990) Differentiation repertoire of fibroblastic cells: expression of cytoskeletal proteins as marker of phenotypic modulations. Lab Invest 63:144–161

46.

Schlaepfer

Hunter

(1996) Signal transduction from the extracellular matrix—a role for the focal adhesion protein-tyrosine kinase FAK. Cell Struct Funct 21:445–450

47.

Schmitt-Graff

Desmouliere

Gabbiani

(1994) Heterogeneity of myofibroblast phenotypic features: an example of fibroblastic cell plasticity. Virchows Arch 425:3–24

48.

Schwarzbauer

(1991) Alternative splicing of fibronectin: three variants, three functions. Bioessays 13:527–533

49.

Schwarzbauer

Paul

Hynes

(1985) On the origin of species of fibronectin. Proc Natl Acad Sci USA 82:1424–1428

50.

Serini

Bochaton-Piallat

M-L

Ropraz

Geinoz

Borsi

Zardi

Gabbiani

(1998) The fibronectin domain ED-A is crucial for myofibroblastic phenotype induction by transforming growth factor-β1. J Cell Biol 142:873–881

51.

Tang

Van

(1997) Myofibroblast and α₁(III) collagen expression in experimental tubulointerstitial nephritis. Kidney Int 51:926–931

52.

Tuchweber

Desmouliere

Bochaton-Piallat

Bubbia-Brandt

Gabbiani

(1996) Proliferation and phenotypic modulation of portal fibroblasts in the early stages of cholestatic fibrosis in the rat. Lab Invest 74:265–278

53.

Xia

Culp

(1995) Adhesion activity in fibronectin's alternatively spliced domain EDa (EIIIA): complementarity to plasma fibronectin functions. Exp Cell Res 217:517–527

54.

Yamamoto

Noble

Cohen

Nast

Hishida

Gold

Border

(1996) Expression of transforming growth factor-beta isoforms in human glomerular diseases. Kidney Int 49:461–469

55.

Yamamoto

Noble

Miller

Border

(1994) Sustained expression of TGF-β1 underlies development of progressive kidney fibrosis. Kidney Int 45:916–927

56.

Zhang

Flanders

Phan

(1995) Cellular localization of transforming growth factor-β expression in bleomycin-induced pulmonary fibrosis. Am J Pathol 147:352–361